| Lisa R Thomas, MD | |
|
119 Gannett Dr, South Portland, ME 04106-6942 | |
| (207) 774-2642 | |
| (207) 774-4293 |
| Full Name | Lisa R Thomas |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 31 Years |
| Location | 119 Gannett Dr, South Portland, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508892449 | NPI | - | NPPES |
| 269070099 | Medicaid | ME | |
| 30201604 | Medicaid | NH | |
| 038667 | Other | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD15368 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine Medical Center | Portland, ME | Hospital |
| Memorial Hospital, The | North conway, NH | Hospital |
| Waldo County General Hospital | Belfast, ME | Hospital |
| Stephens Memorial Hospital | Norway, ME | Hospital |
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
| Maine Medical Partners | 9335043967 | 789 |
| Memorial Hospital | 2365418993 | 86 |
News Archive
A split course of high-dose radiotherapy in men with progressive, hormone-refractory prostate cancer is effective and has an acceptable toxicity profile, report Australian researchers.
Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
A comprehensive review of four decades of national homicide data show important gender differences and trends among homicide victims and offenders in the U.S., related to prevalence and the characteristics of the crimes and the men and women involved.
British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors' latest fund, SV7 Impact Medicine Fund, to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.
› Verified 1 days ago
| Entity Name | Mercy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629078712 PECOS PAC ID: 6103737812 Enrollment ID: O20040217000943 |
News Archive
A split course of high-dose radiotherapy in men with progressive, hormone-refractory prostate cancer is effective and has an acceptable toxicity profile, report Australian researchers.
Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
A comprehensive review of four decades of national homicide data show important gender differences and trends among homicide victims and offenders in the U.S., related to prevalence and the characteristics of the crimes and the men and women involved.
British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors' latest fund, SV7 Impact Medicine Fund, to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.
› Verified 1 days ago
| Entity Name | Central Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689653487 PECOS PAC ID: 2567379563 Enrollment ID: O20040324000441 |
News Archive
A split course of high-dose radiotherapy in men with progressive, hormone-refractory prostate cancer is effective and has an acceptable toxicity profile, report Australian researchers.
Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
A comprehensive review of four decades of national homicide data show important gender differences and trends among homicide victims and offenders in the U.S., related to prevalence and the characteristics of the crimes and the men and women involved.
British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors' latest fund, SV7 Impact Medicine Fund, to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.
› Verified 1 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104921535 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000274 |
News Archive
A split course of high-dose radiotherapy in men with progressive, hormone-refractory prostate cancer is effective and has an acceptable toxicity profile, report Australian researchers.
Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
A comprehensive review of four decades of national homicide data show important gender differences and trends among homicide victims and offenders in the U.S., related to prevalence and the characteristics of the crimes and the men and women involved.
British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors' latest fund, SV7 Impact Medicine Fund, to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.
› Verified 1 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
A split course of high-dose radiotherapy in men with progressive, hormone-refractory prostate cancer is effective and has an acceptable toxicity profile, report Australian researchers.
Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
A comprehensive review of four decades of national homicide data show important gender differences and trends among homicide victims and offenders in the U.S., related to prevalence and the characteristics of the crimes and the men and women involved.
British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors' latest fund, SV7 Impact Medicine Fund, to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa R Thomas, MD 301c Us Route One, Scarborough, ME 04074-9701 Ph: (207) 396-8600 | Lisa R Thomas, MD 119 Gannett Dr, South Portland, ME 04106-6942 Ph: (207) 774-2642 |
News Archive
A split course of high-dose radiotherapy in men with progressive, hormone-refractory prostate cancer is effective and has an acceptable toxicity profile, report Australian researchers.
Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
A comprehensive review of four decades of national homicide data show important gender differences and trends among homicide victims and offenders in the U.S., related to prevalence and the characteristics of the crimes and the men and women involved.
British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors' latest fund, SV7 Impact Medicine Fund, to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.
› Verified 1 days ago
Dr. Jonathan B Zuckerman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Road, West Building Suite 103, South Portland, ME 04106 Phone: 207-828-1122 Fax: 207-828-0188 | |
Laureen A Biczak, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd, Ste 3, South Portland, ME 04106 Phone: 207-774-5816 Fax: 207-523-8594 | |
Pamela Egan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 265 Western Ave Ste 2, South Portland, ME 04106 Phone: 207-661-0200 | |
Sylvia Vania Alarcon Velasco, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 265 Western Ave Ste 2, South Portland, ME 04106 Phone: 207-661-0200 | |
Dr. Christopher G Tretter, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Mainehealth Cancer Care, 265 Western Ave Suite 2, South Portland, ME 04106 Phone: 207-661-0200 | |
Dr. Emily V Wood, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd, Ste 3, South Portland, ME 04106 Phone: 207-774-5816 Fax: 207-523-8594 | |
Dr. Daniel J Diekema, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 41 Donald B Dean Dr, South Portland, ME 04106 Phone: 207-661-7901 |